IDEXX Laboratories Valuation

IDXX Stock  USD 450.90  0.20  0.0444%   
Do you wonder what the value of IDEXX Laboratories is? Calculating the true value of any business or its net worth is not as easy as it may seem. While the market cap of a public entity, such as IDEXX Laboratories, is its stock price multiplied by the total number of shares outstanding, calculating IDEXX Laboratories' enterprise value.requires a different approach. It uses IDEXX Laboratories' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Free Cash Flow is likely to drop to about 379.4 M in 2023. Enterprise Value is likely to drop to about 30.5 B in 2023.
IDEXX Laboratories retains a regular Real Value of $488.15 per share. The prevalent price of the firm is $450.9. At this time, the firm appears to be undervalued. Our model calculates the value of IDEXX Laboratories from inspecting the firm fundamentals such as Return On Asset of 0.22 %, return on equity of 0.94 %, and Operating Margin of 0.27 % as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we encourage acquiring undervalued assets and dropping overvalued assets since, in the future, asset prices and their ongoing real values will come together.
IDEXX Laboratories Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as IDEXX Laboratories's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

IDEXX Most Recent Valuation Data

Change Receivables
-41.4 M
Fiscal Year End
Property Plant And Equipment Net
649.5 M
Enterprise Value
37 B
Today 450.90
Please note that IDEXX Laboratories' price fluctuation is very steady at this time. Calculation of the real value of IDEXX Laboratories is based on 3 months time horizon. Increasing IDEXX Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for IDEXX Laboratories is useful when determining the fair value of the IDEXX stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of IDEXX Laboratories. Since IDEXX Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IDEXX Stock. However, IDEXX Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
The real value of a stock, also known as the intrinsic value, is the underlying worth of a company that is reflected in its stock price. It is based on the company's financial performance, assets, liabilities, growth prospects, management team, industry conditions, and other relevant factors. The real value of a stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, price-to-book ratio, and other valuation metrics. The real value of a stock may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence the stock's price. It is important to note that the real value of a stock is not a fixed number and may change over time based on changes in the company's performance and other relevant factors.
Real Value
Estimating the potential upside or downside of IDEXX Laboratories helps investors to forecast how IDEXX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IDEXX Laboratories more accurately as focusing exclusively on IDEXX Laboratories' fundamentals will not take into account other important factors:
Estimates (7)
LowNext ValueHigh
9 Analysts
LowTarget PriceHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use IDEXX Laboratories' intrinsic value based on its ongoing forecasts of IDEXX Laboratories' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against IDEXX Laboratories' closest peers. When choosing an evaluation method for IDEXX Laboratories, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

IDEXX Laboratories Investments

313.85 Million

IDEXX Valuation Drivers Correlation

Many accounts on the financial statements of IDEXX Laboratories are highly interrelated and sometimes correlated. Consequently, when conducting IDEXX's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of IDEXX
Click cells to compare fundamentals

IDEXX Valuation Trend

Knowing IDEXX Laboratories' actual value is paramount for traders to make sound investment determinations. IDEXX Laboratories' real value is not only important for the investor to make better decisions but also for a more accurate overall view of IDEXX Laboratories' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both IDEXX Laboratories' enterprise well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

IDEXX Market Cap

IDEXX Laboratories is rated second overall in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 146.85 Billion. IDEXX Laboratories totals roughly 37.41 Billion in market capitalization claiming about 25% of equities under Health Care industry.
Capitalization  Total debt  Valuation  Revenue  Workforce

IDEXX Laboratories Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining IDEXX Laboratories's current stock value. Our valuation model uses many indicators to compare IDEXX Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IDEXX Laboratories competition to find correlations between indicators driving IDEXX Laboratories's intrinsic value. More Info.
IDEXX Laboratories is rated second overall in beta category among related companies. It is rated third overall in net asset category among related companies making up about  2,304,139,753  of Net Asset per Beta. Average Assets is likely to drop to about 2.4 B in 2023. Tangible Asset Value is likely to drop to about 2.1 B in 2023. Comparative valuation analysis is a catch-all model that can be used if you cannot value IDEXX Laboratories by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for IDEXX Laboratories' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IDEXX Laboratories' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates IDEXX Laboratories' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in IDEXX Laboratories and how it compares across the competition.

About IDEXX Laboratories Valuation

The stock valuation mechanism determines the current worth of IDEXX Laboratories on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of IDEXX Laboratories. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of IDEXX Laboratories based exclusively on its fundamental and basic technical indicators. By analyzing IDEXX Laboratories's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of IDEXX Laboratories's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of IDEXX Laboratories. We calculate exposure to IDEXX Laboratories's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to IDEXX Laboratories's related companies.
Fiscal Year End
Diagnostics & Research
Health Care Equipment
Full Time Employees
10.8 K
Service Category
Health Care Equipment & Supplies
Last ReportedProjected for 2023
Gross ProfitB1.8 B
Profit Margin 0.20  0.20 

IDEXX Laboratories Quarterly Enterprise Value

42.8 Billion

8 Steps to conduct IDEXX Laboratories' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates IDEXX Laboratories' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct IDEXX Laboratories' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain IDEXX Laboratories' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine IDEXX Laboratories' revenue streams: Identify IDEXX Laboratories' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research IDEXX Laboratories' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish IDEXX Laboratories' growth potential: Evaluate IDEXX Laboratories' management, business model, and growth potential.
  • Determine IDEXX Laboratories' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate IDEXX Laboratories' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

IDEXX Laboratories Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as IDEXX Laboratories does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding84.6 M
Quarterly Earnings Growth Y O Y0.123
Forward Price Earnings50.2513

IDEXX Laboratories Current Valuation Indicators

Valuation refers to the process of determining the present value of IDEXX Laboratories and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value IDEXX we look at many different elements of the entity such as IDEXX's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. IDEXX Laboratories' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final IDEXX Laboratories' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as IDEXX Laboratories, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use IDEXX Laboratories' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes IDEXX Laboratories' worth.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as various price indices. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for IDEXX Stock analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.